Publisher
Springer International Publishing
Reference56 articles.
1. Approved Cellular and Gene Therapy Product. (n.d.). U.S. food and drug administration. Accessed 29 July 2021. https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/approved-cellular-and-gene-therapy-products.
2. Araki, M., & Ishii, T. (2014). International regulatory landscape and integration of corrective genome editing into in vitro fertilization. Reproductive Biology and Endocrinology: RB&E, 12(November), 108.
3. Bak, R. O., Gomez-Ospina, N., & Porteus, M. H. (2018). Gene editing on center stage. Trends in Genetics: TIG, 34(8), 600–611.
4. Baltimore, D., Berg, P., Botchan, M., Dana, C., Alta Charo, R., Church, G., Corn, J. E., et al. (2015). Biotechnology. A prudent path forward for genomic engineering and germline gene modification. Science, 348(6230), 36–38.
5. Baylis, F. (2018). Counterpoint: The potential harms of human gene editing using CRISPR-Cas9. Clinical Chemistry, 64(3), 489–491.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献